FDA Arthritis Advisory Committee meeting: postmarketing surveillance of nonsteroidal antiinflammatory drugs.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000453:epidemiology; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration
D000893:Anti-Inflammatory Agents